Description |
xi, 300 pages ; 24 cm |
Contents |
Prelude: The Widow -- 1. Shooting Stars -- 2. Super Aspirin and Poison Pills -- 3. Cox in Paradise -- 4. The Pharmaceutical Miracle -- 5. The Evolution of Ethics in Modern Medicine: How a Dye Changed History -- 6. The Advertising Miracle -- 7. Super Aspirin Is Born -- 8. Discovery -- 9. The Epidemic Blossoms -- 10. The War Begins -- 11. Bursting the Bubble -- 12. The Vioxx Mystique and Hypnotized Water: The Development of Modern Drug Testing -- 13. Is Super Aspirin Safe and Effective? -- 14. The Cool Blonde -- 15. Celebrex Meets the FDA -- 16. Payback Time -- 17. Vioxx Gastrointestinal Outcomes Research (VIGOR) -- 18. Spinning the Results -- 19. Medical "Interpretation" -- 20. Getting Our the Vioxx Message: The Cyber Obstacleizer -- 21. Science in Reverse -- 22. Losing Their Minds -- 23. Path of Destruction -- 24. The Drug Warriors -- 25. FDA vs. FDA -- 26. After the Party -- Coda: The Widow |
Summary |
"With annual sales of $2.5 billion, Vioxx became a pharmaceutical bonanza before being abruptly taken off the market in September 2004, after it was revealed that it led to an increased risk of heart-related disease and death." "Drawing on internal documents, video footage, court testimony, and exclusive interviews, as well as three decades of experience inside the medical industry, Tom Nesi tells the dramatic story of what the drug's manufacturer, Merck, knew and when."--BOOK JACKET |
Bibliography |
Includes bibliographical references (pages [282]-284) and index |
Subject |
Merck & Co.
|
|
Rofecoxib -- Side effects.
|
LC no. |
2008019633 |
ISBN |
031236959X (alk. paper) |
|
9780312369590 (alk. paper) |
|